BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28400634)

  • 1. A Literature Revision in Primary Cutaneous B-cell Lymphoma.
    Selva R; Violetti SA; Delfino C; Grandi V; Cicchelli S; Tomasini C; Fierro MT; Berti E; Pimpinelli N; Quaglino P
    Indian J Dermatol; 2017; 62(2):146-157. PubMed ID: 28400634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
    Sokol L; Naghashpour M; Glass LF
    Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous B-cell lymphoma].
    Cortés B; Prins C
    Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
    Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
    Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
    J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions.
    Kempf W; Kazakov DV; Mitteldorf C
    Am J Dermatopathol; 2014 Mar; 36(3):197-208; quiz 209-10. PubMed ID: 24658377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous B-cell lymphoma: A single-center 5-year experience.
    Jacob LA; Asati V; Lakshmaiah KC; Govind BK; Lokanatha D; Babu SM; Lokesh KN; Rudresh AH; Rajeev LK; Mulchandani NJ; Anand A; Koppaka D; Mysore SN
    Indian J Cancer; 2018; 55(2):134-137. PubMed ID: 30604723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification.
    Bessell EM; Humber CE; O'Connor S; English JS; Perkins W; Dickinson PD; Patel AN
    Br J Dermatol; 2012 Nov; 167(5):1118-23. PubMed ID: 22759204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
    Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
    Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.
    Koens L; Vermeer MH; Willemze R; Jansen PM
    Am J Surg Pathol; 2010 Jul; 34(7):1043-8. PubMed ID: 20551823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous B-cell lymphomas. Current concepts. I.
    Santucci M; Pimpinelli N
    Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous B-cell lymphoma: important diagnostic tools.
    Ferenczi K
    G Ital Dermatol Venereol; 2010 Jun; 145(3):361-73. PubMed ID: 20461044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
    Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
    Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Cutaneous B-Cell Lymphomas.
    Sundram U
    Surg Pathol Clin; 2014 Jun; 7(2):253-83. PubMed ID: 26837201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous B-cell lymphomas with large cell predominance-primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma.
    Hope CB; Pincus LB
    Semin Diagn Pathol; 2017 Jan; 34(1):85-98. PubMed ID: 28065463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
    Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
    Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the T-cell regulatory marker FOXP3 in primary cutaneous large B-cell lymphoma tumour cells.
    Felcht M; Heck M; Weiss C; Becker JC; Dippel E; Müller CS; Nashan D; Sachse MM; Nicolay JP; Booken N; Goerdt S; Klemke CD
    Br J Dermatol; 2012 Aug; 167(2):348-58. PubMed ID: 22512270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous B-cell lymphoma: review and current concepts.
    Pandolfino TL; Siegel RS; Kuzel TM; Rosen ST; Guitart J
    J Clin Oncol; 2000 May; 18(10):2152-68. PubMed ID: 10811681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOX expression in cutaneous B-cell lymphomas.
    Schrader AM; Jansen PM; Willemze R
    Arch Dermatol Res; 2016 Aug; 308(6):423-7. PubMed ID: 27180090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.